FARAPULSE™ Pulsed Field Ablation (PFA) System

FARAPULSE™ Pulsed Field Ablation

The way your heart was born to beat.
Over 200,000 people have found their rhythm again with the FARAPULSE procedure. Find out if it's right for you.

Take the quiz

AFib doesn’t just disrupt the rhythm of your heart. It disrupts the rhythm of your life.

When medications aren’t working to keep your heart in rhythm, there’s FARAPULSE. FARAPULSE is an advanced, minimally invasive cardiac ablation procedure that uses quick pulses of electrical energy to precisely target the source of irregular heartbeats. Many people are able to experience life without AFib symptoms,¹ and also without AFib medications that can come with their own unpleasant side effects.²

There are risks associated with all medical procedures. Please talk with your doctor about the risks and benefits of the FARAPULSE procedure.

Could FARAPULSE be right for you?

Find out

Download FARAPULSE brochure

FARAPULSE treats the source of your AFib symptoms safely and effectively.

Low rate of serious adverse events¹

People showed no recurrence of AFib symptoms at one year after the procedure^4†

People remained free of AFib medications at one year after the procedure¹

People were very satisfied with AFib symptom relief^1,5

If medications aren’t working to manage your AFib, talk with your doctor about FARAPULSE.

Your doctor understands your health situation best and can help guide you.

Living with AFib isn’t easy.

Atrial fibrillation (AFib) is an irregular heartbeat that can make the heart work less efficiently, causing symptoms like:

Racing or fluttering heartbeats
Chest discomfort
Shortness of breath (especially when active)
Tiredness
Weakness
Dizziness or light-headedness

Dancing, vibing woman with pulse indication over her heart and FARAPULSE Pulsed Field Ablation (PFA) shape behind her

AFib can worsen over time.

At first, you may have occasional AFib episodes with symptoms that come and go, but last less than a week. This is known as paroxysmal AFib. Even with medication, it may progress to persistent AFib, where episodes last longer than a week and usually require treatment to help restore a normal heart rhythm. The more time your heart spends in AFib, the higher the risk of blood clots, stroke and heart failure.⁶

Cardiac ablation is shown to be the most effective treatment for reducing AFib progression.^7,8

Studies have shown that people who have an ablation earlier were more likely to have better symptom control, less AFib over time, and a lower risk of complications compared with those who waited.^9,10

FARAPULSE is the next generation of safe, effective cardiac ablation.

How cardiac ablation works.

This minimally invasive procedure treats the areas inside the heart where irregular rhythms begin. Next to the heart is an important nerve and the esophagus.

Traditional cardiac ablation

Thermal energy burns or freezes tissue in the heart causing irregular beats, but may damage surrounding areas as well.

FARAPULSE Pulsed Field Ablation (PFA)

Quick pulses of electrical energy target the cells that cause irregular heartbeats, without affecting nearby areas.

In a study of 17,000+ patients, FARAPULSE had zero reports of the serious adverse events seen in traditional thermal-based cardiac ablation—and an overall serious  adverse event rate of less than 1%.^3*

Back to the beat they were born with.

Hear about FARAPULSE from people who had the procedure.

Meet Jeana

I no longer have to consider whether I’ll have the energy to ride my bike for a few miles or walk for a few blocks.

Meet Mike

I don’t have to take an antiarrhythmic and I’m very, very pleased about that.

Have questions about the FARAPULSE procedure?

Our FARAPULSE Education Specialists can help answer your questions about the procedure.

Call 1 (855) 442-7725

References:

1. Reddy VY, Gerstenfeld EP, Natale A, et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. New England Journal of Medicine. 2023;Nov2;389(18):1660–1671. doi:10.1056/NEJMoa2307291.
2. National Heart, Lung, and Blood Institute. Atrial Fibrillation Treatment. National Heart, Lung, and Blood Institute. Updated November 30, 2022. Accessed March 4, 2025. https://www.nhlbi.nih.gov/health/atrial-fibrillation/treatment
3. Ekanem E, Neuzil P, Reichlin T, et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study. Nat Med. 30, 2020–2029 (2024). https://www.nature.com/articles/s41591-024-03114-3
4. Turagam MK, Neuzil P, Schmidt B, et al. Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry. Circulation. 2023 May 18;148(1):35–46.
5. Boston Scientific. Data on file. 2025.
6. Shah AJ, Hocini M, Komatsu Y, et al. The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. J Atr Fibrillation. 2013;6(2):849. Published 2013 Aug 31. doi:10.4022/jafib.849
7. Kuck KH, Lebedev DS, Mikhaylov EN, et al. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST). Europace. 2021 Mar 8;23(3):362–369. doi:10.1093/europace/euaa298. PMID: 33330909; PMCID: PMC7947582.
8. Benali K, et al. Catheter ablation of paroxysmal atrial fibrillation and disease progression: magnitude of the antiprogression effect and role of intervention timing. Heart Rhythm. 2025;0(0).
9. Gunawardene MA, Willems S. Atrial fibrillation progression and the importance of early treatment for improving clinical outcomes. Europace. 2022;24(Suppl 2):ii22–ii28. doi:10.1093/europace/ euab257
10. 2023 ACC Guidelines. Circulation. 2024;149e156. Access at https://www.ahajournals.org/doi/10.1161/CIR.0000000000001193

^*In a clinical trial the major adverse event rate was 0.98% (n=17,642). Due to the retrospective nature of the registry, the adverse event rate was not reported at a prespecified time point. Serious adverse events include atrioesophageal fistula, pulmonary vein stenosis, or persistent phrenic nerve injury.
^†In a clinical trial 81.6% of people with paroxysmal AFib had no atrial fibrillation, atrial flutter or atrial tachycardia after a single ablation procedure at 12 months.

Important Safety Information

The FARAPULSE Pulsed Field Ablation (PFA) System is intended for the isolation of the pulmonary veins in the treatment of paroxysmal atrial fibrillation by rendering targeted cardiac tissue electrically non-conductive to prevent cardiac arrhythmia initiation or maintenance. With all medical procedures there are risks associated with the use of the device. The risks include but are not limited to pain or discomfort, electric shock, hypotension, infection/inflammation, allergic reaction, anesthesia risk, radiation injury/tissue burn, heart failure, renal failure, respiratory distress, arrhythmia, nerve injury (such as phrenic nerve or vagal nerve), gastrointestinal disorders, vessel trauma, cardiac trauma (such as perforation), injury related to adjacent structures (esophageal injury, atrio-esophageal fistula, pulmonary injury), pulmonary vein stenosis, surgical and access complications, muscle spasm, injury due to blood clot or air bubbles in the lungs or other organs, heart attack, TIA, stroke, and/or damage to red blood cells. In rare cases, cardiac arrest or death may occur. Be sure to talk with your doctor so that you thoroughly understand all of the risks and benefits associated with the procedure and use of the device. EP-1801404-AA